Birbara C - Search Results

1

Frequency, predictors, and economic impact of upward dose adjustment of infliximab in managed care patients with rheumatoid arthritis.

Ollendorf DA, Massarotti E, Birbara C, Burgess SM. Ollendorf DA, et al. Among authors: birbara c. J Manag Care Pharm. 2005 Jun;11(5):383-93. doi: 10.18553/jmcp.2005.11.5.383. J Manag Care Pharm. 2005. PMID: 15934797 Free PMC article.

2

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.

Kavanaugh A, Krueger GG, Beutler A, Guzzo C, Zhou B, Dooley LT, Mease PJ, Gladman DD, de Vlam K, Geusens PP, Birbara C, Halter DG, Antoni C; IMPACT 2 Study Group. Kavanaugh A, et al. Among authors: birbara c. Ann Rheum Dis. 2007 Apr;66(4):498-505. doi: 10.1136/ard.2006.058339. Epub 2006 Nov 17. Ann Rheum Dis. 2007. PMID: 17114188 Free PMC article. Clinical Trial.

3

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.

Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C, Zhou B, Dooley LT, Kavanaugh A; IMPACT 2 Trial Investigators. Antoni C, et al. Among authors: birbara c. Ann Rheum Dis. 2005 Aug;64(8):1150-7. doi: 10.1136/ard.2004.032268. Epub 2005 Jan 27. Ann Rheum Dis. 2005. PMID: 15677701 Free PMC article. Clinical Trial.

4

Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.

Kaine JL, Kivitz AJ, Birbara C, Luo AY. Kaine JL, et al. Among authors: birbara c. J Rheumatol. 2007 Feb;34(2):272-9. J Rheumatol. 2007. PMID: 17304653 Clinical Trial.

5

Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.

van der Heijde D, Kavanaugh A, Gladman DD, Antoni C, Krueger GG, Guzzo C, Zhou B, Dooley LT, de Vlam K, Geusens P, Birbara C, Halter D, Beutler A. van der Heijde D, et al. Among authors: birbara c. Arthritis Rheum. 2007 Aug;56(8):2698-707. doi: 10.1002/art.22805. Arthritis Rheum. 2007. PMID: 17665424 Free article. Clinical Trial.

6

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK. Furst DE, et al. J Rheumatol. 2003 Dec;30(12):2563-71. J Rheumatol. 2003. PMID: 14719195 Clinical Trial.

7

Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum. A comparison with C-reactive protein.

Kumon Y, Loose LD, Birbara CA, Sipe JD. Kumon Y, et al. Among authors: birbara ca. J Rheumatol. 1997 Jan;24(1):14-9. J Rheumatol. 1997. PMID: 9002005

8

Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.

Emery P, Kosinski M, Li T, Martin M, Williams GR, Becker JC, Blaisdell B, Ware JE Jr, Birbara C, Russell AS. Emery P, et al. Among authors: birbara c. J Rheumatol. 2006 Apr;33(4):681-9. Epub 2006 Mar 1. J Rheumatol. 2006. PMID: 16568505 Clinical Trial.

9

Effect of psoriatic arthritis on ixekizumab clinical outcomes in moderate-to-severe psoriasis patients: A post hoc analysis.

Gottlieb AB, Papp KA, Birbara CA, Shuler CL, Burge R, Erickson J, Kerr L, Mease PJ. Gottlieb AB, et al. Among authors: birbara ca. J Am Acad Dermatol. 2018 Sep;79(3):593-595. doi: 10.1016/j.jaad.2018.03.008. Epub 2018 Mar 17. J Am Acad Dermatol. 2018. PMID: 29559395 No abstract available.

10

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.

Ritchlin C, Rahman P, Kavanaugh A, McInnes IB, Puig L, Li S, Wang Y, Shen YK, Doyle MK, Mendelsohn AM, Gottlieb AB; PSUMMIT 2 Study Group. Ritchlin C, et al. Ann Rheum Dis. 2014 Jun;73(6):990-9. doi: 10.1136/annrheumdis-2013-204655. Epub 2014 Jan 30. Ann Rheum Dis. 2014. PMID: 24482301 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters